Intragastric implants with collapsible frames

US9681974B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9681974-B2
Application numberUS-201414519692-A
CountryUS
Kind codeB2
Filing dateOct 21, 2014
Priority dateOct 19, 2010
Publication dateJun 20, 2017
Grant dateJun 20, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Transoral obesity treatment devices and related methods for operation thereof are described which occupy space within a stomach and/or stimulate the stomach wall. The transoral obesity treatment devices and related methods are intended to assist a patient in maintaining a healthy body weight. Features of the devices include insertion transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The life span of these devices may be material-dependent upon long-term survivability within an acidic stomach, but is intended to last one year or longer. The devices have the capacity to vary in size and are desirably self-actuating in that they change shape and/or volume using internal motors or actuators. The changing character of the devices helps prevent the person's stomach from compensating for the implant, such as sometimes happens with static intragastric devices.

First claim

Opening claim text (preview).

What is claimed is: 1. An intragastric obesity treatment implant, comprising: a first collapsible/expandable frame formed of a first plurality of spaced struts each extending between first end poles along a generally helical path, the first frame having a size sufficient to contact the interior stomach walls upon contraction thereof, the first frame being capable of being converted into a substantially linear delivery configuration by displacing the first end poles away from one another and being formed of a material that will resist degradation over a period of at least six months within the stomach; a second collapsible/expandable frame formed of a second plurality of spaced struts each extending between second end poles along a generally helical path; and an intermediate tether connecting the first and second frames in series. 2. The implant of claim 1 , further including a flexible material draped around and connected to at least one of the first and second frames so as to span across spaces between the struts of each draped frame. 3. The implant of claim 2 , wherein the flexible material is a porous mesh. 4. The implant of claim 2 , wherein the flexible material is impermeable and each draped frame of the implant is filled with saline. 5. The implant of claim 1 , wherein the struts of each frame are discrete wires retained together at the respective end poles of each frame. 6. The implant of claim 1 , wherein for each frame the respective struts are interwoven to define a sphere when relaxed. 7. The implant of claim 6 , wherein the helical struts of at least one of the first frame and the second frame all wind around the sphere in one direction between the end poles, CW or CCW. 8. The implant of claim 6 , wherein the helical struts of at least one of the first frame and the second frame wind around the sphere in two directions between the end poles, CW and CCW, to form a braided mesh. 9. The implant of claim 1 , wherein the shape of each collapsible/expandable frame is adjustable in vivo. 10. The implant of claim 1 , wherein the struts of at least one of the first frame and the second frame are Nitinol wires and the ends of the wires are held by end caps of silicone. 11. The implant of claim 1 , further comprising: a third collapsible/expandable frame formed of a third plurality of spaced struts; and an intermediate tether between the second and third frames in series. 12. The implant of claim 1 , further including a duodenal anchor connected to a distal one of the frames, the duodenal anchor having a size that permits it to pass through the pyloric sphincter and be formed of a material of sufficient mass and specific gravity that prevents it from migrating back up through the pyloric sphincter. 13. The implant of claim 1 , wherein a proximal one of the frames includes an internally threaded sleeve suitable for receiving an externally threaded end of a delivery tube. 14. The implant of claim 1 , wherein the intermediate tether is tubular permitting passage of a stiff rod through the series of frames. 15. The implant of claim 1 , further including a flexible material draped around and connected to each of the first and second frames so as to span across the spaces between the first plurality and second plurality of struts. 16. An intragastric obesity treatment implant, comprising: a collapsible/expandable frame formed of a plurality of spaced articulable struts each extending between end poles, the frame having a relaxed generally spherical configuration with a size sufficient to contact the interior stomach walls upon contraction thereof, the frame being capable of being converted into a substantially linear delivery configuration by displacing the poles away from one another and being formed of a material that will resist degradation over a period of at least six months within the stomach, wherein the struts include joints displaced between the end poles. 17. The implant of claim 16 , further including a flexible material draped around and connected to the frame so as to span across the spaces between the struts. 18. The implant of claim 16 , wherein the joints are hinges and wherein each strut is comprised of a plurality of stiff members connected together between the poles by at least one hinge.

Assignees

Inventors

Classifications

  • having rigid linking arm pivotally connected to each gripping member · CPC title

  • inflatable · CPC title

  • with position locking-means for gripping members · CPC title

  • Apparatus for the treatment of obesity; Anti-eating devices (surgical instruments or methods for treatment of obesity, devices specially adapted therefor A61B17/00; hollow or tubular parts of organs A61F2/04) · CPC title

  • preventing normal digestion, e.g. Bariatric or gastric sleeves · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9681974B2 cover?
Transoral obesity treatment devices and related methods for operation thereof are described which occupy space within a stomach and/or stimulate the stomach wall. The transoral obesity treatment devices and related methods are intended to assist a patient in maintaining a healthy body weight. Features of the devices include insertion transorally and without invasive surgery, without associated …
Who is the assignee on this patent?
Apollo Endosurgery Inc, Apollo Endosurgery Us Inc
What technology area does this patent fall under?
Primary CPC classification A61F5/0036. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).